Andecaliximab (Anti-MMP9)
Andecaliximab (Anti-MMP9) is a recombinant chimeric IgG4 monoclonal antibody (mAb) that targets matrix metalloproteinase 9 (MMP9). Andecaliximab shows antifibrotic efficacy in idiopathic pulmonary fibrosis mouse models. MW: 145.5 kD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2399 |
| Sku # | A2399-1mg*25 |
| Pricing | 1mg*25, $2370.00 |